Reach Us +1-504-608-239
R.D. Neelima Vardhani | OMICS International
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

R.D. Neelima Vardhani


Dubious Action of Atrazine as an Endocrine Disrupting Agent: An In silico Approach

Atrazine is chlorine containing chemical compound which is widely used as an herbicide. However, upon its entry into the human body, it is known to affect several organs and their functions. Additionally, atrazine also represses photosynthesis in plants and causes serious disorders in animals as well. One of the most challenging actions of atrazine... Read More»

Shailima Rampogu, R.D. Neelima Vardhani, SSNP Ekke and Rajesh Goud Gajula

Research Article: J Cancer Clin Trials 2017, 2:132

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics